Phibro Animal Health Corp PAHC

US Pharmaceuticals
$36.33 β–Ό -0.33% ($-0.12)
Open $36.19
Prev Close $36.45
Day Range $35.32 – $36.58
52W Range $25.58 – $60.08
Market Cap $1.47B
P/E (TTM) 15.26
Beta 0.47
Div Yield 1.32%
EPS (TTM) $2.33

πŸ“‹ Company Profile

IndustryPharmaceuticals
CountryUS
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD
IPO Date2014-04-11
Shares Out.40,560,000
Websitepahc.com/ β†—
Phone12013297300
Employees2,475
Revenue$383.5M
Gross Profit$125.7M
Net Income$24.0M
Free Cash Flow$12.8M
Total Assets$1.45B
Total Liabilities$1.08B
Equity$361.8M
About Phibro Animal Health Corp

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S.Β and other international countries.

Phibro Animal Health Corp is a publicly traded company under the ticker symbol PAHC on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.

πŸ“Š Analyst Ratings

10 analysts (2026-07-01)

Buy 1
Hold 5
Sell 2
Strong Sell 2

πŸ‘₯ Related Stocks